Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Buys 60,000 Shares of Company Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 60,000 shares of Senestech stock in a transaction on Wednesday, October 21st. The stock was purchased at an average price of $0.74 per share, for a total transaction of $44,400.00. Following the completion of the transaction, the insider owned 2,159,473 shares of the company’s stock, valued at approximately $1,598,010.02. This represents a 2.86% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Thursday, October 22nd, Glenbrook Capital Management acquired 7,500 shares of Senestech stock. The shares were purchased at an average cost of $0.80 per share, for a total transaction of $6,000.00.
• On Tuesday, October 20th, Glenbrook Capital Management acquired 36,375 shares of Senestech stock. The shares were purchased at an average cost of $0.67 per share, with a total value of $24,371.25.
• On Monday, October 19th, Glenbrook Capital Management acquired 376,552 shares of Senestech stock. The shares were purchased at an average cost of $0.70 per share, with a total value of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management bought 181,252 shares of Senestech stock. The stock was purchased at an average price of $0.63 per share, with a total value of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management bought 426,000 shares of Senestech stock. The stock was purchased at an average price of $0.77 per share, with a total value of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management bought 6,490 shares of Senestech stock. The stock was acquired at an average cost of $1.30 per share, for a total transaction of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The stock was acquired at an average cost of $1.30 per share, for a total transaction of $19,500.00.

Senestech Price Performance

NASDAQ SNES opened at $0.80 on Friday. Senestech, Inc. has a one year low of $0.55 and a one year high of $3.90. The stock’s 50 day simple moving average is $0.89 and its 200 day simple moving average is $1.32. The company has a debt-to-equity ratio of 0.02, a quick ratio of 5.81 and a current ratio of 6.78.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.02. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. The firm had revenue of $0.77 million during the quarter, compared to analysts’ expectations of $0.60 million. Sell-side analysts anticipate that Senestech, Inc. will post -1.28 EPS for the current fiscal year.

Institutional Investors Weigh In On Senestech

A hedge fund recently bought a new stake in Senestech stock. Diversify Wealth Management LLC bought a new position in Senestech, Inc. (NASDAQ:SNES) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech at the end of the most recent quarter. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, Senestech has a consensus rating of “Sell”.

About Senestech

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.